Drug Research
Pfizer and BioNTech Receive First U.S. FDA EUA of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Pfizer Inc. and BioNTech SE announced that the U.S. FDA has authorized for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11...
Drug Research
WuXi Biologics Launches a New GMP Commercial Drug Product Facility
WuXi Biologics, a global company with leading open-access biologics technology platforms, announced it has successfully launched the GMP operation of its new drug product...
Drug Research
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII),...
News
Cryoviva Singapore Gets AABB Accreditation for Somatic Cells Processing, Storage, and Distribution
Family cord blood bank Cryoviva Singapore is pleased to announce that it has now been accredited by the Association of the Advancement of Blood...
Press Releases
PreOmics launches BeatBox at ASMS 2021 for high throughput tissue homogenization
PreOmics, developer of innovative tools for mass spectrometry-based protein analyses, has announced the launch of BeatBox, its new sample preparation tool for tissues and...
News
End-to-End Multi-Attribute Method Solution Accelerates Biotherapeutic Development and Manufacturing
Biopharmaceutical laboratories working across R&D, manufacturing and quality control (QC) environments can now streamline biopharmaceutical characterization, process monitoring and release testing using a new...
Press Releases
Built-for-Purpose Offering Delivers High-Confidence Results for Biomolecule Attribute Monitoring
Biopharmaceutical laboratories can now benefit from high-quality mass information delivered by Orbitrap technology for molecule attribute monitoring in development and quality control (QC). This...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read